Form 4: Evolent Health General Counsel Jonathan Weinberg Reports Changes in Beneficial Ownership

Jonathan Weinberg, General Counsel of Evolent Health, reports acquisition and disposal of Class A Common Stock due to vesting of restricted stock units and tax withholding.

Summary

• On March 1, 2024, Jonathan Weinberg, General Counsel of Evolent Health, acquired 21,822 shares of Class A Common Stock upon vesting of restricted stock units.
• These securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
• Also on March 1 and 2, 2024, Mr. Weinberg disposed of 7,460 and 4,830 shares of Class A Common Stock, respectively, at a price of $34.41, to satisfy tax withholding obligations.
• Following these transactions, Mr. Weinberg beneficially owns 167,027 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects routine transactions related to executive compensation and does not indicate any significant positive or negative sentiment.

Future Outlook

The restricted stock units vest over a three-year period, starting March 1, 2025.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.

Key Dates